Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model

Journal of Psychiatric Research

Volumn 46, Issue 10, 2012, Pages 1359-1365

  Filiou, Michaela D ^a   Teplytska, Larysa ^a   Otte, David M ^b   Zimmer, Andreas ^b   Turck, Christoph W ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

15N metabolic labeling; G72; Myelination; Oxidative stress; Quantitative proteomics; Schizophrenia

Indexed keywords

LG72 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; IN VIVO STUDY; MALE; MASS SPECTROMETRY; MOUSE; MYELINATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SCHIZOPHRENIA;

ANIMALS; CARRIER PROTEINS; CATALASE; CEREBELLUM; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MASS SPECTROMETRY; MICE; MICE, TRANSGENIC; MUTATION; NERVE FIBERS, MYELINATED; NITROGEN ISOTOPES; OXIDATIVE STRESS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA;

EID: 84865543418     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.07.004     Document Type: Article

References (46)

1. Abou Jamra R., Schmael C., Cichon S., Rietschel M., Schumacher J., Nothen M.M. The G72/G30 gene locus in psychiatric disorders: a challenge to diagnostic boundaries?. Schizophrenia Bulletin 2006, 32:599-608.
2. Andreasen N.C., Pierson R. The role of the cerebellum in schizophrenia. Biological Psychiatry 2008, 64:81-88.
3. Barabasi A.L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nature Reviews Genetics 2011, 12:56-68.
4. Ben-Shachar D., Laifenfeld D. Mitochondria, synaptic plasticity, and schizophrenia. International Review of Neurobiology 2004, 59:273-296.
5. Benitez-King G., Ramirez-Rodriguez G., Ortiz L., Meza I. The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia. Current Drug Targets-CNS & Neurological Disorders 2004, 3:515-533.
6. Bronstein J.M., Micevych P.E., Chen K. Oligodendrocyte-specific protein (OSP) is a major component of CNS myelin. Journal of Neuroscience Research 1997, 50:713-720.
7. Brunner C., Lassmann H., Waehneldt T.V., Matthieu J.M., Linington C. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. Journal of Neurochemistry 1989, 52:296-304.
8. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:13675-13680.
9. Ciobica A., Padurariu M., Dobrin I., Stefanescu C., Dobrin R. Oxidative stress in schizophrenia - focusing on the main markers. Psychiatria Danubina 2011, 23:237-245.
10. Clay H.B., Sillivan S., Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. International Journal of Developmental Neuroscience 2011, 29:311-324.
11. Dracheva S., Davis K.L., Chin B., Woo D.A., Schmeidler J., Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiology of Disease 2006, 21:531-540.
12. Eastwood S.L., Cotter D., Harrison P.J. Cerebellar synaptic protein expression in schizophrenia. Neuroscience 2001, 105:219-229.
13. Filiou M.D., Bisle B., Reckow S., Teplytska L., Maccarrone G., Turck C.W. Profiling of mouse synaptosome proteome and phosphoproteome by IEF. Electrophoresis 2010, 31:1294-1301.
14. Filiou M.D., Turck C.W., Martins-de-Souza D. Quantitative proteomics for investigating psychiatric disorders. Proteomics - Clinical Applications 2011, 5:38-49.
15. Filiou M.D., Zhang Y., Teplytska L., Reckow S., Gormanns P., Maccarrone G., et al. Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biological Psychiatry 2011, 70:1074-1082.
16. Filiou M.D., Turck C.W. Psychiatric disorder biomarker discovery using quantitative proteomics. Methods in Molecular Biology 2012, 829:531-539.
17. 15N-enriched bacteria diet for improved proteomic analyses of mouse models for psychopathologies. PLoS One 2009, 4:e7821.
18. Freedman R. Schizophrenia. New England Journal of Medicine 2003, 2003(349):1738-1749.
19. Glantz L.A., Gilmore J.H., Lieberman J.A., Jarskog L.F. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophrenia Research 2006, 81:47-63.
20. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annual Review of Pharmacology and Toxicology 2005, 45:51-88.
21. Jarskog L.F. Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations. Current Opinion in Psychiatry 2006, 19:307-312.
22. Katsel P., Davis K.L., Haroutunian V. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophrenia Research 2005, 79:157-173.
23. Katsetos C.D., Hyde T.M., Herman M.M. Neuropathology of the cerebellum in schizophrenia-an update: 1996 and future directions. Biological Psychiatry 1997, 42:213-224.
24. Konarski J.Z., McIntyre R.S., Grupp L.A., Kennedy S.H. Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?. Journal of Psychiatry and Neuroscience 2005, 30:178-186.
25. Kvajo M., Dhilla A., Swor D.E., Karayiorgou M., Gogos J.A. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Molecular Psychiatry 2008, 13:685-696.
26. Loeber R.T., Cintron C.M., Yurgelun-Todd D.A. Morphometry of individual cerebellar lobules in schizophrenia. American Journal of Psychiatry 2001, 158:952-954.
27. MacCoss M.J., Wu C.C., Matthews D.E., Yates J.R. Measurement of the isotope enrichment of stable isotope-labeled proteins using high-resolution mass spectra of peptides. Analytical Chemistry 2005, 77:7646-7653.
28. Martínez-Cengotitabengoa M., Mac-Dowell K.S., Leza J.C., Micó J.A., Fernandez M., Echevarría E., et al. Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes. Schizophrenia Research 2012, Mar 22 [Epub ahead of print].
29. Martins-de-Souza D., Gattaz W.F., Schmitt A., Rewerts C., Marangoni S., Novello J.C., et al. Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. Journal of Neural Transmission 2009, 116:275-289.
30. Martins-de-Souza D. Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. Journal of Psychiatric Research 2010, 44:149-156.
31. Martins-de-Souza D., Maccarrone G., Wobrock T., Zerr I., Gormanns P., Reckow S., et al. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia. Journal of Psychiatric Research 2010, 44:1176-1189.
32. Nopoulos P.C., Ceilley J.W., Gailis E.A., Andreasen N.C. An MRI study of cerebellar vermis morphology in patients with schizophrenia: evidence in support of the cognitive dysmetria concept. Biological Psychiatry 1999, 46:703-711.
33. Otte D.M., Bilkei-Gorzo A., Filiou M.D., Turck C.W., Yilmaz O., Holst M.I., et al. Behavioral changes in G72/G30 transgenic mice. European Neuropsychopharmacology 2009, 19:339-348.
34. Otte D.M., Sommersberg B., Kudin A., Guerrero C., Albayram ö., Filiou M.D., et al. N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice. Neuropsychopharmacology 2011, 36:2233-2243.
35. Palmieri F. The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflügers Archiv 2004, 447:689-709.
36. Pan C., Kora G., McDonald W.H., Tabb D.L., VerBerkmoes N.C., Hurst G.B., et al. ProRata: a quantitative proteomics program for accurate protein abundance ratio estimation with confidence interval evaluation. Analytical Chemistry 2006, 78:7121-7131.
37. Paxinos G., Franklin K. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego. 2nd ed.
38. Poduslo J.F., Braun P.E. Topographical arrangement of membrane proteins in the intact myelin sheath. Lactoperoxidase incorporation of iodine into myelin surface proteins. Journal of Biological Chemistry 1975, 250:1099-1105.
39. Raffa M., Mechri A., Othman L.B., Fendri C., Gaha L., Kerkeni A. Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Progress in Neuropsychopharmacology and Biological Psychiatry 2009, 33:1178-1183.
40. Reddy R., Sahebarao M.P., Mukherjee S., Murthy J.N. Enzymes of the antioxidant defense system in chronic schizophrenic patients. Biological Psychiatry 1991, 30:409-412.
41. Stephens S.H., Franks A., Berger R., Palionyte M., Fingerlin T.E., Wagner B., et al. Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia. Psychiatric Genetics 2012, 22:1-14.
42. Sullivan P.F. Puzzling over schizophrenia: schizophrenia as a pathway disease. Nature Medicine 2012, 18:210-211.
43. Tabb D.L., McDonald W.H., Yates J.R. DTASelect and contrast: tools for assembling and comparing protein identifications from shotgun proteomics. Journal of Proteome Research 2002, 1:21-26.
44. Takahashi N., Sakurai T., Davis K.L., Buxbaum J.D. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Progress in Neurobiology 2011, 93:13-24.
45. Tkachev D., Mimmack M.L., Ryan M.M., Wayland M., Freeman T., Jones P.B., et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
46. Zhang Y., Filiou M.D., Reckow S., Gormanns P., Maccarrone G., Kessler M.S., et al. Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways. Molecular and Cellular Proteomics 2011, 10. M111.008110.